AllianceBernstein
KITE

AllianceBernstein’s Kite Pharma, Inc. KITE Stock Holding History

AllianceBernstein’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-84,300
Closed -$15.2M – 3153
2017
Q3 		$15.2M Sell
84,300
-10,900
-11% -$1.52M 0.01% 848
2017
Q2 		$9.87M Buy
95,200
+36,400
+62% +$2.97M 0.01% 934
2017
Q1 		$4.62M Sell
58,800
-2,600
-4% -$161K ﹤0.01% 1237
2016
Q4 		$2.75M Hold
61,400
– – ﹤0.01% 1613
2016
Q3 		$3.43M Hold
61,400
– – ﹤0.01% 1368
2016
Q2 		$3.07M Buy
61,400
+9,326
+18% +$458K ﹤0.01% 1351
2016
Q1 		$2.39M Buy
52,074
+2,274
+5% +$110K ﹤0.01% 1462
2015
Q4 		$3.07M Buy
49,800
+200
+0.4% +$14.1K ﹤0.01% 1312
2015
Q3 		$2.76M Sell
49,600
-50
-0.1% -$3.15K ﹤0.01% 1402
2015
Q2 		$3.03M Buy
49,650
+36,900
+289% +$2.11M ﹤0.01% 1453
2015
Q1 		$735K Buy
12,750
+2,900
+29% +$194K ﹤0.01% 2338
2014
Q4 		$568K Buy
+9,850
New +$415K ﹤0.01% 2477

AllianceBernstein's KITE Position: Q4 2017 in Review

AllianceBernstein sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 84,300 shares — an estimated $15.2M sold.

AllianceBernstein first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $15.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • AllianceBernstein reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • AllianceBernstein sold 84,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $15.2M.
  • AllianceBernstein first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • AllianceBernstein's Kite Pharma, Inc. position peaked at $15.2M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on AllianceBernstein's 13F filing for Q4 2017, filed 13 Feb 2018.